Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion
Chanèle Cyr-Depauw1, Jason J Northey1, Sébastien Tabariès2
1Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada Department of Biochemistry, McGill University, Montréal, Québec, Canada.
Abstract:
ShcA is an important mediator of ErbB2- and transforming growth factor β (TGF-β)-induced breast cancer cell migration, invasion, and metastasis. We show that in the context of reduced ShcA levels, the bone morphogenetic protein (BMP) antagonist chordin-like 1 (Chrdl1) is upregulated in numerous breast cancer cells following TGF-β stimulation. BMPs have emerged as important modulators of breast cancer aggressiveness, and we have investigated the ability of Chrdl1 to block BMP-induced increases in breast cancer cell migration and invasion. Breast cancer-derived conditioned medium containing elevated concentrations of endogenous Chrdl1, as well as medium containing recombinant Chrdl1, suppresses BMP4-induced signaling in multiple breast cancer cell lines. Live-cell migration assays reveal that BMP4 induces breast cancer migration, which is effectively blocked by Chrdl1. We demonstrate that BMP4 also stimulated breast cancer cell invasion and matrix degradation, in part, through enhanced metalloproteinase 2 (MMP2) and MMP9 activity that is antagonized by Chrdl1. Finally, high Chrdl1 expression was associated with better clinical outcomes in patients with breast cancer. Together, our data reveal that Chrdl1 acts as a negative regulator of malignant breast cancer phenotypes through inhibition of BMP signaling.
Insights
Chordin-like 1 (Chrdl1) inhibits bone morphogenetic protein (BMP) signaling, reducing breast cancer cell migration and invasion. High Chrdl1 expression correlates with better patient outcomes, suggesting a protective role in breast cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- ShcA mediates ErbB2 and transforming growth factor β (TGF-β) effects on breast cancer metastasis.
- Bone morphogenetic proteins (BMPs) are increasingly recognized for their role in breast cancer aggressiveness.
Purpose of the Study:
- To investigate the role of chordin-like 1 (Chrdl1) as a BMP antagonist in breast cancer.
- To determine if Chrdl1 can inhibit BMP-induced breast cancer cell migration and invasion.
Main Methods:
- Upregulation of Chrdl1 in breast cancer cells after TGF-β stimulation.
- Treatment of breast cancer cells with Chrdl1-containing medium or recombinant Chrdl1.
- Assessment of BMP4-induced signaling, cell migration, invasion, and matrix metalloproteinase (MMP) activity.
- Analysis of Chrdl1 expression in patient data.
Main Results:
- Chrdl1 suppresses BMP4-induced signaling in breast cancer cells.
- Chrdl1 effectively blocks BMP4-stimulated breast cancer cell migration and invasion.
- BMP4-induced matrix degradation via MMP2 and MMP9 is antagonized by Chrdl1.
- Higher Chrdl1 expression in patients is linked to improved clinical outcomes.
Conclusions:
- Chrdl1 functions as a negative regulator of malignant breast cancer phenotypes.
- Chrdl1 inhibits breast cancer progression by antagonizing BMP signaling pathways.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Cancer Cell Migration through Invadopodia
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Abnormal Proliferation
Negative Regulator Molecules

